Genetic Technology Alert. Sound Wave-Based Point of Care Diagnostic Device for Biomarker Detection; Novel Methodology to Detect Antiviral Antibody Interactions

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles a sound wave-based point of care diagnostic device for biomarker detection, a novel methodology to detect antiviral antibody interactions, and placenta-on-a-chip technology for understanding placental function

Table of Contents

Genetic Technology Alert. Sound Wave-Based Point of Care Diagnostic Device for Biomarker Detection; Novel Methodology to Detect Antiviral Antibody InteractionsIn This Issue1. SOUND WAVE-BASED POINT OF CARE DIAGNOSTIC DEVICE FOR BIOMARKER DETECTION2. NOVEL METHODOLOGY TO DETECT ANTIVIRAL ANTIBODY INTERACTIONS3. PLACENTA-ON-A-CHIP TECHNOLOGY FOR UNDERSTANDING PLACENTAL FUNCTION4. RECENT PATENTS IN CANCER DRUGS5. TECHVISION 2015




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.